Selway Asset Management’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $2.7M | Sell |
23,879
-1,300
| -5% | -$139K | 1.11% | 30 |
|
|
2024
Q4 | $2.66M | Buy |
25,179
+40
| +0.2% | +$4.29K | 1.04% | 32 |
|
|
2024
Q3 | $2.71M | Hold |
25,139
| – | – | 1.06% | 32 |
|
|
2024
Q2 | $2.73M | Buy |
25,139
+80
| +0.3% | +$9.43K | 1.11% | 28 |
|
|
2024
Q1 | $3.31M | Buy |
25,059
+4,420
| +21% | +$552K | 1.32% | 28 |
|
|
2023
Q4 | $2.51M | Sell |
20,639
-125
| -0.6% | -$13.9K | 1.06% | 31 |
|
|
2023
Q3 | $2.33M | Sell |
20,764
-275
| -1% | -$34.9K | 1.07% | 32 |
|
|
2023
Q2 | $3.06M | Sell |
21,039
-800
| -4% | -$109K | 1.34% | 29 |
|
|
2023
Q1 | $2.82M | Sell |
21,839
-800
| -4% | -$100K | 1.35% | 30 |
|
|
2022
Q4 | $2.89M | Hold |
22,639
| – | – | 1.53% | 24 |
|
|
2022
Q3 | $2.37M | Sell |
22,639
-900
| -4% | -$98.8K | 1.38% | 26 |
|
|
2022
Q2 | $2.47M | Buy |
23,539
+535
| +2% | +$63.5K | 1.37% | 25 |
|
|
2022
Q1 | $2.94M | Buy |
23,004
+7,962
| +53% | +$960K | 1.42% | 27 |
|
|
2021
Q4 | $1.85M | Buy |
15,042
+206
| +1% | +$27K | 0.88% | 38 |
|
|
2021
Q3 | $2.11M | Buy |
14,836
+819
| +6% | +$120K | 1.15% | 31 |
|
|
2021
Q2 | $2.19M | Hold |
14,017
| – | – | 1.17% | 30 |
|
|
2021
Q1 | $2.18M | Buy |
14,017
+371
| +3% | +$57.5K | 1.27% | 26 |
|
|
2020
Q4 | $2.04M | Sell |
13,646
-4,429
| -25% | -$626K | 1.24% | 28 |
|
|
2020
Q3 | $2.39M | Sell |
18,075
-103
| -0.6% | -$13.5K | 1.69% | 21 |
|
|
2020
Q2 | $2.11M | Buy |
18,178
+6,489
| +56% | +$748K | 1.67% | 20 |
|
|
2020
Q1 | $1.15M | Buy |
11,689
+1,133
| +11% | +$149K | 1.11% | 32 |
|
|
2019
Q4 | $1.53M | Sell |
10,556
-1,133
| -10% | -$156K | 1.06% | 36 |
|
|
2019
Q3 | $1.56M | Sell |
11,689
-17,542
| -60% | -$2.27M | 1.14% | 34 |
|
|
2019
Q2 | $3.34M | Sell |
29,231
-824
| -3% | -$96.5K | 2.24% | 12 |
|
|
2019
Q1 | $3.73M | Buy |
30,055
+1,633
| +6% | +$186K | 2.49% | 11 |
|
|
2018
Q4 | $2.86M | Sell |
28,422
-93
| -0.3% | -$10.5K | 2.11% | 16 |
|
|
2018
Q3 | $3.64M | Sell |
28,515
-1,854
| -6% | -$220K | 2.19% | 15 |
|
|
2018
Q2 | $3.29M | Sell |
30,369
-2,776
| -8% | -$302K | 2.01% | 16 |
|
|
2018
Q1 | $3.51M | Sell |
33,145
-1,144
| -3% | -$133K | 2.18% | 15 |
|
|
2017
Q4 | $4.02M | Sell |
34,289
-360
| -1% | -$40.7K | 2.36% | 11 |
|
|
2017
Q3 | $3.94M | Buy |
34,649
+103
| +0.3% | +$11.9K | 2.28% | 12 |
|
|
2017
Q2 | $4.31M | Sell |
34,546
-3,399
| -9% | -$403K | 2.46% | 8 |
|
|
2017
Q1 | $4.5M | Buy |
37,945
+206
| +0.5% | +$23.3K | 2.53% | 8 |
|
|
2016
Q4 | $3.78M | Buy |
37,739
+515
| +1% | +$55.2K | 2.26% | 12 |
|
|
2016
Q3 | $4.7M | Sell |
37,224
-876
| -2% | -$108K | 2.92% | 5 |
|
|
2016
Q2 | $4.45M | Hold |
38,100
| – | – | 2.86% | 7 |
|
|
2016
Q1 | $3.94M | Buy |
+38,100
| New | +$3.69M | 2.72% | 8 |
|
|
2013
Q3 | – | Sell |
-5,449
| Closed | -$396K | – | 76 |
|
|
2013
Q2 | $396K | Buy |
+5,449
| New | +$407K | 0.24% | 63 |
|
Other funds holding ZBH
Selway Asset Management's ZBH Position: Q1 2025 in Review
Selway Asset Management reduced its Zimmer Biomet (ZBH) stake by 5.2% in Q1 2025, selling an estimated $139K and leaving 23,879 shares worth $2.7M. The position accounts for 1.11% of the portfolio, ranked #30.
Selway Asset Management first reported a position in ZBH in Q2 2013 and has held it in 38 quarters since. The position peaked at $4.7M in Q3 2016. 1,000 funds tracked by Wall St. Rank hold ZBH as of Q1 2025.
- Selway Asset Management held 23,879 shares of Zimmer Biomet worth $2.7M as of Q1 2025.
- Selway Asset Management sold 1,300 Zimmer Biomet shares in Q1 2025, an estimated $139K.
- Zimmer Biomet made up 1.11% of Selway Asset Management's portfolio in Q1 2025, its #30 holding.
- Selway Asset Management first reported a position in Zimmer Biomet in Q2 2013 and has held it in 38 quarters since.
- Selway Asset Management's Zimmer Biomet position peaked at $4.7M in Q3 2016.
- 1,000 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2025.
Based on Selway Asset Management's 13F filing for Q1 2025, filed 9 Apr 2025.